Evidence map›Paper›PMID 36559319›Full record

ArticlePharmaceutics2022

Protein Modification Employing Non-Canonical Amino Acids to Prepare SUMOylation Detecting Bioconjugates.

Alexander C Williard, Hannah J Switzer, Christina A Howard, Rui Yin, Brent L Russell, Ritwik Sanyal, Shaun Yu, Trinity M Myers, Brian M Flood, Oliver Kerscher and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alexander C WilliardDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Hannah J SwitzerDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.ORCID 0000-0002-7355-3787
Christina A HowardDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Rui YinDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.ORCID 0000-0001-5330-8306
Brent L RussellDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Ritwik SanyalDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Shaun YuDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Trinity M MyersDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Brian M FloodDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
Oliver KerscherDepartment of Biology, William & Mary, Williamsburg, VA 23185, USA.
Douglas D YoungDepartment of Chemistry, William & Mary, Williamsburg, VA 23185, USA.ORCID 0000-0003-4433-4101
William & Mary · US

Funding

Genetic requirements for executing SUMO stress signals and achieving stress toleranceR15GM147883 · NIGMS · COLLEGE OF WILLIAM AND MARY · PI KERSCHER, OLIVER NONE · 2022 to 2022
$436k
NIGMS NIH HHS R15 GM147883
6 · The paper itself

Abstract

Protein modification with non-canonical amino acids (ncAAs) represents a useful technology to afford homogenous samples of bioconjugates with site-specific modification. This technique can be directly applied to the detection of aberrant SUMOylation patterns, which are often indicative of disease states. Modified SUMO-trapping proteins, consisting of a catalytically inactive ULP1 fragment (UTAG) fused to the maltose-binding protein MBP, are useful reagents for the binding and labeling of SUMOylated proteins. Mutation of this UTAG fusion protein to facilitate amber suppression technologies for the genetic incorporation of ncAAs was assessed to provide a functional handle for modification. Ultimately, two sites in the maltose-binding protein (MBP) fusion were identified as ideal for incorporation and bioconjugation without perturbation to the SUMO-trapping ability of the UTAG protein. This functionality was then employed to label SUMOylated proteins in HeLa cells and demonstrate their enrichment in the nucleus. This modified UTAG-MBP-ncAA protein has far-reaching applications for both diagnostics and therapeutics.

Indexed as

bioconjugatesnon-canonical amino acidsprotein modificationSUMO

Identifiers

PMID36559319
PMCPMC9784311
OpenAlexW4312141179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.